https://www.marketscreener.com/quote/stock/CELGENE-8736/news/Celgene-U-S-FDA-Approves-INREBIC-Fedratinib-as-First-New-Treatment-in-Nearly-a-Decade-for-Pat-29075826/?utm_source=telegram&utm_medium=social&utm_campaign=share